Ticker Details
Arcutis Biotherapeutics, Inc.
IPO Date:	January 31, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$3.11B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.58 | 3.35%
Avg Daily Range (30 D):	$0.63 | 2.36%
Avg Daily Range (90 D):	$0.65 | 2.50%

Institutional Daily Volume
Avg Daily Volume:	1.15M
Avg Daily Volume (30 D):	1.12M
Avg Daily Volume (90 D):	1.6M

Trade Size
Avg Trade Size (Sh.):	99
Avg Trade Size (Sh.) (30 D):	61
Avg Trade Size (Sh.) (90 D):	67

Institutional Trades
Total Institutional Trades:	2,269
Avg Institutional Trade:	$2.17M
Avg Institutional Trade (30 D):	$2.77M
Avg Institutional Trade (90 D):	$3.83M
Avg Institutional Trade Volume:	.16M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.8M
Avg Closing Trade (30 D):	$4.48M
Avg Closing Trade (90 D):	$6.61M
Avg Closing Volume:	202.85K

News

Feb 6, 2026 @ 10:18 AM This Biopharma Stock Has Surged Nearly 100% and On... Source: Jonathan Ponciano

Feb 5, 2026 @ 9:00 PM Arcutis Biotherapeutics Reports Inducement Grants ... Source: Not Specified

Jan 22, 2026 @ 9:00 PM Arcutis to Report Fourth Quarter and Full Year 202... Source: Na

Jan 21, 2026 @ 1:00 PM Nationwide Survey Underscores Concerns with Use of... Source: Arcutis Biotherapeutics, Inc.

Dec 23, 2025 @ 5:18 PM Arcutis Stock Is Up 100% in a Year but Hereâ€â„... Source: Jonathan Ponciano

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-.34	$.06	$-.13
Diluted EPS	$-.34	$.06	$-.13
Revenue	$317.93M	$99.22M	$81.5M
Gross Profit	$286.02M	$90.53M	$74.01M
Net Income / Loss	$-44.32M	$7.41M	$-15.89M
Operating Income / Loss	$-38.25M	$8.53M	$-14.61M
Cost of Revenue	$31.91M	$8.69M	$7.49M
Net Cash Flow	$-87.92M	$-25.53M	$19.13M
PE Ratio